Skip to content

Clinical trials

Completed Cholangiocarcinoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Status: Completed Country / region: South Korea Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20111
20131
20142
20151
20161
20175
20182
20196
20202
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center2
Merck Sharp & Dohme LLC2
ASLAN Pharmaceuticals1
Basilea Pharmaceutica1
Bayer1
Boehringer Ingelheim1
CHA University1
Changhoon Yoo1
Cheju Halla General Hospital1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma26
Biliary Tract Neoplasms8
Bile Duct Neoplasms4
Carcinoma, Hepatocellular4
Esophageal Neoplasms4
Gallbladder Neoplasms4
Neoplasms4
Pancreatic Neoplasms4
Stomach Neoplasms4
Carcinoma, Non-Small-Cell Lung3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.